Unresectable Gallbladder Cancer Terminated Phase 1 Trials for Veliparib (DB07232)

IndicationStatusPhase
DBCOND0028792 (Unresectable Gallbladder Cancer)Terminated1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01282333Veliparib, Cisplatin, and Gemcitabine Hydrochloride in Treating Patients With Advanced Biliary, Pancreatic, Urothelial, or Non-Small Cell Lung CancerTreatment